5:43 PM
Jul 26, 2013
 |  BC Extra  |  Top Story

CHMP says pancreatic toxicity study flawed

EMA's CHMP said a cadaver study published in March suggesting that glucagon-like peptide-1 (GLP-1) receptor agonists and dipeptidyl peptidase-4 (DPP-4) inhibitors -- collectively known as incretin mimetics -- may increase the risk of pancreatic toxicity "had a...

Read the full 174 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >